Pharmaceutical and Biotech Industries Increase Use of Continuous Processing
This free webinar will be presented by Lawrence De Belder, Senior Principal Engineer Continuous Manufacturing at Johnson and Johnson, and Bob Lenich, Director of Life Sciences Business at Emerson
When: Tuesday, May 19, 2020, 4 AM EDT
How: Register to Gain Access to the On-Demand Webinar
Several large pharmaceutical companies have chosen the path of continuous manufacturing, and announced they will use this platform as their default for development and, consequently, commercial manufacturing of their Oral Solid dose drug product pipeline.
During this webinar, the presenters will explain the consequences of this decision, as well as different strategies to handle a pipeline that can be highly dynamic. Different techniques will be discussed that can be used to bring products, with bad flow properties, into a continuous process. Impact of different equipment in development, clinical, and commercial environments will be detailed out, and mitigations will be proposed to overcome these differences. All will be placed in front of a background of regulatory requirements, changing market demand, and evolving strategies of equipment vendors.